Innospec Total Current Liabilities vs Net Debt Analysis

IOSP Stock

USD 119.03 2.82 2.31%

Innospec financial indicator trend analysis is infinitely more than just investigating Innospec recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innospec is a good investment. Please check the relationship between Innospec Total Current Liabilities and its Net Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.

Total Current Liabilities vs Net Debt

Total Current Liabilities vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innospec Total Current Liabilities account and Net Debt. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Innospec's Total Current Liabilities and Net Debt is -0.45. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Net Debt in the same time period over historical financial statements of Innospec, assuming nothing else is changed. The correlation between historical values of Innospec's Total Current Liabilities and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Innospec are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Total Current Liabilities i.e., Innospec's Total Current Liabilities and Net Debt go up and down completely randomly.

Correlation Coefficient

-0.45

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Innospec balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Innospec are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Most indicators from Innospec's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innospec current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.At this time, Innospec's Selling General Administrative is relatively stable compared to the past year. As of 11/18/2024, Enterprise Value Over EBITDA is likely to grow to 18.87, while Tax Provision is likely to drop slightly above 43.6 M.

	2021	2022	2023	2024 (projected)
Gross Profit	434.9M	586.7M	582.8M	318.7M
Total Revenue	1.5B	2.0B	1.9B	2.0B

Gross Profit Total Revenue

Innospec fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		-0.09	0.85	0.91	0.84	0.81	-0.34	0.79	0.89	0.58	0.93	0.11	0.56	0.79	0.01	0.31	0.87	0.17	0.42	0.83	0.53	0.77	0.12	-0.21	0.36	0.36
Short Long Term Debt Total	-0.09		-0.39	-0.26	-0.39	-0.28	0.91	-0.47	-0.26	-0.37	0.15	0.18	-0.38	-0.35	0.48	0.87	-0.39	-0.43	0.24	0.41	-0.34	-0.43	0.43	0.84	-0.51	-0.51
Other Current Liab	0.85	-0.39		0.86	0.74	0.6	-0.56	0.75	0.77	0.56	0.69	-0.08	0.55	0.68	-0.11	-0.03	0.9	0.15	0.23	0.54	0.39	0.73	-0.21	-0.42	0.58	0.58
Total Current Liabilities	0.91	-0.26	0.86		0.8	0.79	-0.45	0.75	0.97	0.57	0.76	0.34	0.55	0.83	0.07	0.06	0.93	0.22	0.52	0.72	0.56	0.81	0.26	-0.25	0.24	0.24
Total Stockholder Equity	0.84	-0.39	0.74	0.8		0.96	-0.66	0.98	0.76	0.84	0.75	0.12	0.82	0.95	-0.43	0.0	0.76	0.36	0.08	0.61	0.83	0.96	0.04	-0.47	0.36	0.37
Property Plant And Equipment Net	0.81	-0.28	0.6	0.79	0.96		-0.54	0.92	0.77	0.76	0.76	0.32	0.74	0.94	-0.3	0.05	0.69	0.34	0.21	0.63	0.88	0.91	0.28	-0.34	0.15	0.16
Net Debt	-0.34	0.91	-0.56	-0.45	-0.66	-0.54		-0.73	-0.42	-0.72	-0.09	0.09	-0.72	-0.6	0.57	0.72	-0.55	-0.49	0.2	0.14	-0.61	-0.7	0.33	0.85	-0.55	-0.56
Retained Earnings	0.79	-0.47	0.75	0.75	0.98	0.92	-0.73		0.71	0.86	0.66	0.03	0.86	0.93	-0.54	-0.09	0.76	0.4	-0.04	0.51	0.83	0.97	-0.09	-0.58	0.48	0.49
Accounts Payable	0.89	-0.26	0.77	0.97	0.76	0.77	-0.42	0.71		0.5	0.73	0.32	0.48	0.82	0.08	0.08	0.9	0.28	0.53	0.71	0.55	0.78	0.28	-0.27	0.25	0.24
Cash	0.58	-0.37	0.56	0.57	0.84	0.76	-0.72	0.86	0.5		0.43	0.12	1.0	0.78	-0.52	-0.15	0.55	0.39	-0.08	0.35	0.83	0.88	-0.01	-0.5	0.36	0.37
Non Current Assets Total	0.93	0.15	0.69	0.76	0.75	0.76	-0.09	0.66	0.73	0.43		0.1	0.41	0.68	0.08	0.54	0.66	0.02	0.41	0.9	0.46	0.62	0.21	0.03	0.17	0.17
Non Currrent Assets Other	0.11	0.18	-0.08	0.34	0.12	0.32	0.09	0.03	0.32	0.12	0.1		0.11	0.25	0.45	0.01	0.09	0.03	0.65	0.26	0.35	0.18	0.92	0.41	-0.7	-0.7
Cash And Short Term Investments	0.56	-0.38	0.55	0.55	0.82	0.74	-0.72	0.86	0.48	1.0	0.41	0.11		0.77	-0.54	-0.16	0.54	0.4	-0.1	0.34	0.82	0.87	-0.03	-0.5	0.37	0.38
Net Receivables	0.79	-0.35	0.68	0.83	0.95	0.94	-0.6	0.93	0.82	0.78	0.68	0.25	0.77		-0.4	0.01	0.76	0.36	0.13	0.64	0.86	0.97	0.17	-0.41	0.27	0.28
Common Stock Shares Outstanding	0.01	0.48	-0.11	0.07	-0.43	-0.3	0.57	-0.54	0.08	-0.52	0.08	0.45	-0.54	-0.4		0.29	-0.09	-0.36	0.81	0.15	-0.45	-0.48	0.57	0.66	-0.51	-0.52
Non Current Liabilities Total	0.31	0.87	-0.03	0.06	0.0	0.05	0.72	-0.09	0.08	-0.15	0.54	0.01	-0.16	0.01	0.29		-0.05	-0.27	0.24	0.72	-0.12	-0.09	0.28	0.66	-0.22	-0.22
Inventory	0.87	-0.39	0.9	0.93	0.76	0.69	-0.55	0.76	0.9	0.55	0.66	0.09	0.54	0.76	-0.09	-0.05		0.32	0.33	0.58	0.44	0.79	-0.03	-0.49	0.52	0.52
Other Current Assets	0.17	-0.43	0.15	0.22	0.36	0.34	-0.49	0.4	0.28	0.39	0.02	0.03	0.4	0.36	-0.36	-0.27	0.32		0.07	0.0	0.42	0.43	-0.11	-0.4	0.25	0.25
Other Stockholder Equity	0.42	0.24	0.23	0.52	0.08	0.21	0.2	-0.04	0.53	-0.08	0.41	0.65	-0.1	0.13	0.81	0.24	0.33	0.07		0.46	0.04	0.06	0.68	0.45	-0.4	-0.41
Total Liab	0.83	0.41	0.54	0.72	0.61	0.63	0.14	0.51	0.71	0.35	0.9	0.26	0.34	0.64	0.15	0.72	0.58	0.0	0.46		0.39	0.56	0.39	0.26	-0.01	-0.01
Property Plant And Equipment Gross	0.53	-0.34	0.39	0.56	0.83	0.88	-0.61	0.83	0.55	0.83	0.46	0.35	0.82	0.86	-0.45	-0.12	0.44	0.42	0.04	0.39		0.85	0.24	-0.35	0.14	0.14
Total Current Assets	0.77	-0.43	0.73	0.81	0.96	0.91	-0.7	0.97	0.78	0.88	0.62	0.18	0.87	0.97	-0.48	-0.09	0.79	0.43	0.06	0.56	0.85		0.05	-0.51	0.37	0.38
Short Term Debt	0.12	0.43	-0.21	0.26	0.04	0.28	0.33	-0.09	0.28	-0.01	0.21	0.92	-0.03	0.17	0.57	0.28	-0.03	-0.11	0.68	0.39	0.24	0.05		0.58	-0.8	-0.8
Intangible Assets	-0.21	0.84	-0.42	-0.25	-0.47	-0.34	0.85	-0.58	-0.27	-0.5	0.03	0.41	-0.5	-0.41	0.66	0.66	-0.49	-0.4	0.45	0.26	-0.35	-0.51	0.58		-0.76	-0.76
Common Stock Total Equity	0.36	-0.51	0.58	0.24	0.36	0.15	-0.55	0.48	0.25	0.36	0.17	-0.7	0.37	0.27	-0.51	-0.22	0.52	0.25	-0.4	-0.01	0.14	0.37	-0.8	-0.76		1.0
Common Stock	0.36	-0.51	0.58	0.24	0.37	0.16	-0.56	0.49	0.24	0.37	0.17	-0.7	0.38	0.28	-0.52	-0.22	0.52	0.25	-0.41	-0.01	0.14	0.38	-0.8	-0.76	1.0

Click cells to compare fundamentals

Innospec Account Relationship Matchups

Innospec fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.5B	1.4B	1.6B	1.6B	1.7B	1.0B
Short Long Term Debt Total	92.6M	40.8M	35.6M	45.3M	45.2M	42.9M
Other Current Liab	169.9M	136.4M	171.7M	194.3M	178.1M	107.3M
Total Current Liabilities	303.5M	252.4M	336.6M	405.8M	371.5M	233.9M
Total Stockholder Equity	918.9M	944.9M	1.0B	1.0B	1.1B	1.2B
Property Plant And Equipment Net	231.1M	250.9M	249.8M	266.2M	313.4M	329.1M
Net Debt	16.9M	(64.5M)	(106.2M)	(101.8M)	(158.5M)	(150.6M)
Retained Earnings	755.5M	758.6M	822.9M	924.2M	1.0B	1.1B
Accounts Payable	122M	98.7M	148.7M	165.3M	163.6M	88.4M
Cash	75.7M	105.3M	141.8M	147.1M	203.7M	213.9M
Non Current Assets Total	838.5M	831.2M	842.8M	731.1M	821.7M	601.2M
Non Currrent Assets Other	5.9M	8.2M	5M	55.2M	41.3M	32.5M
Cash And Short Term Investments	75.7M	105.3M	141.8M	147.1M	203.7M	213.9M
Net Receivables	292M	221.4M	284.5M	334.6M	359.8M	377.8M
Common Stock Shares Outstanding	24.7M	24.8M	24.9M	25.0M	25.0M	20.1M
Liabilities And Stockholders Equity	1.5B	1.4B	1.6B	1.6B	1.7B	1.0B
Non Current Liabilities Total	246.4M	200.1M	201.3M	157.5M	186.3M	170.8M
Inventory	244.6M	220M	277.6M	373.1M	300.1M	169.6M
Other Current Assets	800K	19.5M	24.2M	17.8M	22.1M	23.2M
Other Stockholder Equity	237.5M	242.8M	256.1M	258.7M	266.7M	187.9M
Total Liab	549.9M	452.5M	537.9M	563.3M	557.8M	468.7M
Property Plant And Equipment Gross	231.1M	250.9M	249.8M	266.2M	637.4M	669.3M
Total Current Assets	630.3M	566.2M	728.1M	872.6M	885.7M	930.0M
Accumulated Other Comprehensive Income	(74.4M)	(57.3M)	(46.9M)	(145.2M)	(148.1M)	(140.7M)
Short Term Debt	11.6M	11.8M	12.5M	27.8M	27.2M	21.1M
Intangible Assets	113.5M	75.3M	57.5M	45M	57.3M	54.4M
Other Liab	165.4M	171.1M	178.2M	126.1M	145.0M	101.8M
Other Assets	130.9M	175M	171.2M	61.1M	70.3M	86.2M
Good Will	363M	371.2M	364.3M	358.8M	399.3M	304.3M
Property Plant Equipment	198.7M	210.8M	249.8M	220.9M	254.0M	266.7M
Net Tangible Assets	463.9M	526.8M	611.2M	634.2M	729.3M	765.8M
Retained Earnings Total Equity	755.5M	758.6M	822.9M	924.2M	1.1B	628.1M
Long Term Debt Total	205.8M	187.7M	59.1M	100K	115K	109.3K

Pair Trading with Innospec

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Innospec position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innospec will appreciate offsetting losses from the drop in the long position's value.

Moving together with Innospec Stock

0.63	CC	Chemours	Pair Corr
0.76	ECVT	Ecovyst	Pair Corr

Moving against Innospec Stock

0.44	ASH	Ashland Global Holdings	Pair Corr
0.39	DNMR	Danimer Scientific	Pair Corr

The ability to find closely correlated positions to Innospec could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Innospec when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Innospec - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Innospec to buy it.

The correlation of Innospec is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Innospec moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Innospec moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Innospec can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Innospec Stock Analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC